Publications

Export 178 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Ménard C, Quirion R, Vigneault E, Bouchard S, Ferland G, Mestikawy SEl, Gaudreau P.  2015.  Glutamate presynaptic vesicular transporter and postsynaptic receptor levels correlate with spatial memory status in aging rat models.. Neurobiol Aging. 36(3):1471-82.
Menear M, Gilbert M, MJ Fleury.  2017.  Améliorer la santé mentale des populations par l’intégration des soins de santé mentale aux soins primaires. 42(1):243-271.
Menear M, Gilbert M, MJ Fleury.  0.  [Improving population mental health by integrating mental health care into primary care].. Sante Ment Que. 42(1):243-271.
Meng X, Brunet A, Turecki G, Liu A, D'Arcy C, Caron J..  2017.  Risk factor modifications and depression incidence: a 4-year longitudinal Canadian cohort of the Montreal Catchment Area Study.. BMJ Open. 7(6):e015156.
Meng X, D'Arcy C.  2015.  Comorbidity between lifetime eating problems and mood and anxiety disorders: results from the Canadian Community Health Survey of Mental Health and Well-being.. Eur Eat Disord Rev. 23(2):156-62.
Meng X, MJ Fleury, Xiang Y-T, Li M, D'Arcy C.  2018.  Resilience and protective factors among people with a history of child maltreatment: a systematic review.. Soc Psychiatry Psychiatr Epidemiol. 53(5):453-475.
Meng X, MJ Fleury, Bamvita JM, Grenier G, Caron J..  2018.  Changes in percentages of perceived met needs for care over time in a Canadian longitudinal cohort.. Psychiatry Res. 269:579-584.
Meng X.  2017.  What characteristics are associated with earlier onset of first depressive episodes: A 16-year follow-up of a national population-based cohort.. Psychiatry Res. 258:427-433.
Meng X, D'Arcy C, G Adams C.  2015.  Associations between adult attachment style and mental health care utilization: Findings from a large-scale national survey.. Psychiatry Res. 229(1-2):454-61.
Meng X, D'Arcy C.  2015.  Coping strategies and distress reduction in psychological well-being? A structural equation modelling analysis using a national population sample. Epidemiol Psychiatr Sci. :1-14.
Meng X, Muggli T, Baetz M, D'Arcy C.  2017.  Disordered lives: Life circumstances and clinical characteristics of very frequent users of emergency departments for primary mental health complaints.. Psychiatry Res. 252:9-15.
Meng X, D'Arcy C.  2016.  Gender moderates the relationship between childhood abuse and internalizing and substance use disorders later in life: a cross-sectional analysis.. BMC Psychiatry. 16(1):401.
Merner N, d'Arc BForgeot, Bell SC, Maussion G, Peng H, Gauthier J, Crapper L, Hamdan FF, Michaud JL, Mottron L et al..  2016.  A de novo frameshift mutation in chromodomain helicase DNA-binding domain 8 (CHD8): A case report and literature review.. Am J Med Genet A. 170A(5):1225-35.
Messier L, Elisha B, Schmitz N, Gariépy G, Malla A, Lesage A, Boyer R, Wang JL, Strychar I.  2014.  Weight cycling and depressive symptoms in diabetes: a community-based study of adults with type 2 diabetes mellitus in Quebec.. Can J Diabetes. 38(6):456-60.
Meyer P-F, Labonte A, Rosa-Neto P, Poirier J, Breitner JCS.  2019.  No apparent effect of naproxen on CSF markers of innate immune activation.. Ann Clin Transl Neurol. 6(6):1127-1133.
Meyer P-F, Savard M, Poirier J, Morgan D, Breitner JCS.  2019.  Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology.. Alzheimers Dement. 15(9):1160-1171.
Meyer P-F, Tremblay-Mercier J, Leoutsakos J, Madjar C, Lafaille-Maignan M-É, Savard M, Rosa-Neto P, Poirier J, Etienne P, Breitner JCS.  2019.  INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.. Neurology. 92(18):e2070-e2080.
Meyer P-F, Savard M, Poirier J, Labonte A, Rosa-Neto P, Weitz TM, Town T, Breitner JCS.  2018.  Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.. J Alzheimers Dis. 63(2):577-590.
Meyer P-F, McSweeney M, Gonneaud J, Villeneuve S.  2019.  AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention.. Prog Mol Biol Transl Sci. 165:63-106.
Miguel PMaidana, Pereira LOrlandi, Barth B, Filho EJosé de M, Pokhvisneva I, Nguyen TTT, Garg E, Razzolini BRegis, Koh DXin Ping, Gallant H et al..  2019.  Prefrontal Cortex Dopamine Transporter Gene Network Moderates the Effect of Perinatal Hypoxic-Ischemic Conditions on Cognitive Flexibility and Brain Gray Matter Density in Children.. Biol Psychiatry.
Mikkelsen M, Saleh MG, Near J, Chan KL, Gong T, Harris AD, Oeltzschner G, Puts NAJ, Cecil KM, Wilkinson ID et al..  2018.  Frequency and phase correction for multiplexed edited MRS of GABA and glutathione.. Magn Reson Med. 80(1):21-28.
Milella MS, Marengo L, Larcher K, Fotros A, Dagher A, Rosa-Neto P, Benkelfat C, Leyton M.  2014.  Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study.. Neuroimage. 98:195-202.
Miron J, Picard C, Labonte A, Auld D, Breitner JCS, Poirier J.  2019.  Association of PPP2R1A with Alzheimer's disease and specific cognitive domains.. Neurobiol Aging. 81:234-243.
Miron J, Picard C, Frappier J, Dea D, Théroux L, Poirier J.  2018.  TLR4 Gene Expression and Pro-Inflammatory Cytokines in Alzheimer's Disease and in Response to Hippocampal Deafferentation in Rodents.. J Alzheimers Dis. 63(4):1547-1556.
Miron J, Picard C, Nilsson N, Frappier J, Dea D, Théroux L, Poirier J.  2018.  CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.. Alzheimers Dement.

Pages